Ras Protooncogene Activation in Acute Myeloid Leukemia and Related Disorders

References

• Barbacid M. ras genes. Ann Rev Bioch 1987; 56: 779–827
   PubMed Web of Science ®Google Scholar
• Bos J. L. The ras gene family in human carcinogenesis. Mutat Res 1988; 195: 255–271
   PubMed Web of Science ®Google Scholar
• Needleman S. W. Retroviral and cellular oncogenes, Ch. 8 in Comprehensive Textbook of Oncology, A. R. Moosa, S. C. Schimpff. Williams and Wilkins, Baltimore 1989
   Google Scholar
• Yuasa Y., Eva A., Kraus M. H., Srivastava S., Needleman S. W., Pierce J. H., Rhim J. S., Reddy E. P., Tronick S. R., Aaronson S. A. Ras-related oncogenes of human tumors. Cancer Cell: Oncogenes and Viral Genes, G. Vandewoude. Cold Spring Harbor Monographs, New York 1984; 439, 433
   Google Scholar
• Weinberg R. A. Ras oncogenes and the molecular mechanisms of carcinogenesis. Blood. 1984; 1143–1145
   Google Scholar
• Der C. J., Krontiris T. G., Cooper G. M. Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses. Proc Natl Acad Sci USA 1982; 79: 3637
   PubMed Web of Science ®Google Scholar
• Parada L. F., Tabin C. J., Shih C., Weinberg R. A. Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene. Nature 1982; 297: 474–478
   PubMed Web of Science ®Google Scholar
• Reddy E. P., Reynolds R. K., Santos E., Barbacid M. A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature 1982; 300: 149–153
   PubMed Web of Science ®Google Scholar
• Tabin C. J., Bradley S. M., Bargmann C. I., Weinberg R. A., Papageorge A. G., Scolnick E. M., Dhar R., Lowy D. R., Chang E. H. Mechanisms of activation of a human oncogene. Nature 1982; 300: 143–147; 2
   PubMed Web of Science ®Google Scholar
• Taparowsky E., Suard Y., Fasano O., Shimizu K., Goldfarb M., Wigler M. Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change. Nature 1983; 300: 762–766
   Web of Science ®Google Scholar
• Chang E. H., Furth M. E., Scolnick E. M., Lony D. R. Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey Murine sarcoma virus. Nature 1982; 297: 479–483
   PubMed Web of Science ®Google Scholar
• Wigler M. The role of ras in oncogenesis. Adv. Onc 1986; 2: 1–7
   Google Scholar
• Shimizu K., Goldfarb M., Perucho M., Wigler M. Isolation and preliminary characterization of the transforming gene of a human neuroblastoma cell line. Proc Natl Acad Sci USA 1986; 80: 383–387
   Web of Science ®Google Scholar
• Shimizu K., Birnbaum D., Ruley M. A., Fasano O., Suard Y., Edlund L., Taparowsky E., Goldfarb M., Wigler M. Structure of the Ki-ras gene of the human lung carcinoma cell line Calu-1. Nature 1983; 304: 450–497
   Web of Science ®Google Scholar
• Konkel D. A. What do ras oncogenes do?. Mol Endoc 1988; 2: 883–885
   PubMed Web of Science ®Google Scholar
• Gilman A. G. G proteins and dual control of adenylate. Cell 1984; 36: 577–579
   PubMed Web of Science ®Google Scholar
• Wakelam M. J. O., Davies S. A., Houslay M. D., McKay I., Marshall C. J., Hall A. Normal p21N-res couples bombesin and other growth factor receptors to inositol phosphate production. Nature 1986; 323: 173–176
   PubMed Web of Science ®Google Scholar
• Wolfman A., Macara I. G. Elevated levels of diacylglycerol and decreased phorbol ester sensitivity in ras-transformed fibroblasts. Nature 1987; 325: 359–361
   PubMed Web of Science ®Google Scholar
• Wakelam M. J. O. Inhibition of amplified bombesin-stimulated inositol phosphate response in N-ras transformed cells by high density culturing. Feb 1988; 228: 182–186
   PubMed Web of Science ®Google Scholar
• McGrath J. P., Capon D. J., Goeddel D. V., Levinson A. D. Comparative biochemical properties of normal and activated human ras p21 protein. Nature 1984; 310: 643–649
   Web of Science ®Google Scholar
• Sweet R. W., Yokoyama S., Kamata T., Feramisco J. R., Rosenberg M., Gross M. Nature 1984; 311: 273–275
   PubMed Web of Science ®Google Scholar
• Gibbs J. B., Schaber M. D., Allard W. J., Sigal I. S., Scolnick E. M. Purification of ras GTPase activating protein from bovine brain. Proc Natl Acad Sci 1988; 85: 5026–5030
   PubMed Web of Science ®Google Scholar
• Vogel U. S., Dixon R. A. F., Schaber M. D., Diehl R. E., Marshall M. S., Scolnick E. M., Sigal I. S., Gibbs J. B. Cloning of bovine GAP and its interaction with oncogenic ras p21. Nature 1988; 335: 90–93
   PubMed Web of Science ®Google Scholar
• McCormick F. ras GTPase activating protein: signal transmitter and signal terminator. Cell 1989; 56: 5–8
   PubMed Web of Science ®Google Scholar
• Pulciani S., Santos E., Lauver A. V., Long L. K., Aaronson S. A., Barbacid M. Oncogenes in solid human tumors. Nature 1982; 300: 539–542
   PubMed Web of Science ®Google Scholar
• Fujita J., Yoshida O., Yuasa Y., Rhim J. S., Hatanaka M., Aaronson S. A. Ha-ras oncogenes are activated by somatic alterations in human urinary tract tumors. Nature 1984; 309: 464–468
   PubMed Web of Science ®Google Scholar
• Needleman S. W., Kraus M. H., Srivastava S. K., Levine P. H., Aaronson S. A. High frequency of N-ras activation in acute myelogenous leukemia. Blood 1986; 67: 753–757
   PubMed Web of Science ®Google Scholar
• Bos J. L., Toksoz D., Marshall C. J., Verlaan-deVries M., Veeneman G. H., der Eb A., van Boom J. H., Janssen J. W. G., Steenvoorden A. C. M. Amino acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukemia. Nature 1985; 5: 315, 726–730
   Google Scholar
• Eva A., Tronick S. R., Gol R. A., Pierce J. H., Aaronson S. A. Transforming genes of human hematopoietic tumors: frequent detection of ras-related oncogenes whose activation appears to be independent of tumor phenotype. Proc Natl Acad Sci USA 1983; 80: 4926–4930, 1983.
   PubMed Web of Science ®Google Scholar
• Murray M. J., Cunningham J. M., Parada L. F., Dantry F., Lebowitz P., Weinberg R. A. The HL-60 transforming sequence: A ras oncogene coexisting with altered myc genes in hematopoietic tumors. Cells 1983; 33: 749–753
   PubMed Web of Science ®Google Scholar
• Bos J. L., Verlaan-deVries M., van der Eb A. J., Janssen J. W. G., Derwel R., Lowenberg B., Colly L. P. Mutations in N-ras predominant in acute myeloid leukemia. Blood 1987; 69: 1237–1241
   PubMed Web of Science ®Google Scholar
• Hirai H., Tanaka S., Azuma M., Anraku Y., Urabe A., Takaku F. Transforming genes in human leukemia cells. Blood 1985; 56: 1371–1378, 1985.
   Google Scholar
• Farr C. J., Saiki R. K., Erlich H. A., McCormick F., Marshall C. J. Analysis of ras gene mutation in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes. Proc Natl Acad Sci, USA 1988; 85: 1629–1633
   PubMed Web of Science ®Google Scholar
• Senn H. P., Tran-Thang C., Wodnar-Filipowicz A., Jioricny J., Fopp M., Gratwohl A., Singer E., Weber W., Moroni C. Mutations analysis of the N-ras protooncogene in active and remission phase of human acute leukemias. Int J Cancer 1988; 41: 59–64
   PubMed Web of Science ®Google Scholar
• Bartram C. R. Mutations in ras genes in myelocytic leukemias and myelodysplastic syndromes. Blood Cells 1988; 14: 533–538
   PubMedGoogle Scholar
• Janssen J. W. G., Steenvoorden A. C. M., Lyone J., Anger B., Bos J. L., Bartram C. R. Ras gene mutations in acute and chronic myelogenous leukemia, chronic myeloproliferative disorders, and myelodysplastic syndromes. Proc Natl. Acad, Sci, USA 1987; 7: 84, 9228–9232
   Google Scholar
• Hirai H., Nishida J., Takaku F. Highly frequent detection of transforming genes in acute leukemias by transfection using in vivo selection assays. Biochem Biophys Res Comm 1987; 147: 108–114
   PubMed Web of Science ®Google Scholar
• Mane S. M., Meltzer S. J., Kapil V., Gutheil J. C., Lee E. J., Schiffer C. A., Needleman S. W. Ras gene mutations in acute myeloid leukemia: analysis by in vitro amplification and base sequence determination. Blood, submitted
   Google Scholar
• Bos J. L. Ras oncogenes in human cancer: a review. Can Res 1989; 49: 4682–4689
   PubMed Web of Science ®Google Scholar
• Gonzalez N. F., Zhou D., Battifor H., Bareli M., Cline M. J. Direct sequencing analysis of exon-1 of the c-K-ras gene shows a low frequency of mutations in human pancreatic adenocarcinomas. Oncogene 1989; 4: 1137–1140
   PubMed Web of Science ®Google Scholar
• Mallet M., Mane S. M., Meltzer S., Needleman S. W. C-myc amplification coexisting with N-ras point mutation in the biphenotypic cell line RED-3. Leukemia 1989; 3: 511–515
   PubMed Web of Science ®Google Scholar
• Murray M. J., Cunningham J. M., Parada L. F., Dantry F., Lebowitz P., Weinberg R. A. The HL-60 transforming sequence: A ras oncogene coexisting with altered myc genes in hematopoietic tumors. Cells 1983; 33: 749–754
   PubMed Web of Science ®Google Scholar
• Zarbl H., Sukumar S., Arthur A. V., Martin-Zanca D., Barbacid M. Direct mutagenesis of the Ha-ras-I oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats. Nature 1985; 315: 382–385
   PubMed Web of Science ®Google Scholar
• Needleman S. W., Gutheil J. C., Kapil V., Mane S. M. Infrequent activation in chronic myelogenous leukemia; activating second ras exon mutation in the CML-derived cell line, IM-9. Leukemia 1989; 3: 827–928
   PubMed Web of Science ®Google Scholar
• Land H., Parada L. F., Weinberg R. A. Cellular oncogenes and multistep carcinogenesis. Science 1983; 222: 773–778
   Web of Science ®Google Scholar
• Liu E., Hyelle B., Morgan R., Hicht F., Bishop J. M. Mutations of the Kirsten-ras protooncogene in human preleukemia. Nature 1987; 330: 186–188
   PubMed Web of Science ®Google Scholar
• Bar-Eli M., Cadavid N. G., Foti A., Cline M. J. Analysis of N-ras exon-1 mutations in myelodysplastic syndromes by polymerase chain reaction and direct sequencing. Blood 1989; 73: 281–283
   PubMed Web of Science ®Google Scholar
• Lyons J., Janssen J. W. G., Bartram C., Layton M., Mufti G. J. Mutations of ki-ras and N-ras oncogenes in myelodysplastic syndromes. Blood 1988; 71: 1707–1712
   PubMed Web of Science ®Google Scholar
• Hirai H., Kobayashi Y., Mano H. A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome. Nature 1987; 327: 430–432
   PubMed Web of Science ®Google Scholar
• Padua R. A., Carter G., Hughes D. Ras mutations in myelodysplasia detected by amplification, oligonucleotide hybridization, and transformation. Leukemia 1988; 2: 503–510
   PubMed Web of Science ®Google Scholar
• Neri A., Knowles D. M., Greco A., McCormick F., Dalla-Favbara R. Analysis of ras oncogene mutations in human lymphoid malignancies. Proc Nat'l Acad Sci 1988; 85: 9268–9272
   PubMed Web of Science ®Google Scholar
• Rodenhuis S., Bos J. L., Slater R. M., Behrendt H., van't Verr M., Smets L. A. Absence of oncogene amplifications and occasional activation of N-ras in lymphoblastic leukemia of childhood. Blood 1986; 67: 1698–1704
   PubMed Web of Science ®Google Scholar
• Unpublished observations
   Google Scholar
• Sukumar S., Notario V., Zanca D., Barbacid M. Induction of mammary carcinomas in rats by NMU involves malignant activation of H-ras-1 locus by single point mutations. Nature 1983; 306: 658–661
   PubMed Web of Science ®Google Scholar
• Pedersen-Bjergaard J., Janssen J. W. G., Lyons J., Philip P., Bartram C. R. Point mutation of the ras protooncogenes and chromosome aberrations in acute nonlymphocytic leukemia and preleukemia related to therapy with alkylating agents. Cancer Research 1988; 48: 1812–1817
   PubMed Web of Science ®Google Scholar
• Hand P. H., Thor A., Wunderlich D. Monoclonal antibodies of predefined specificity detect activated ras gene expression in human mammary and colon carcinomas. Proc Natl Acad Sci USA 1984; 81: 5227–5231
   PubMed Web of Science ®Google Scholar
• Lundy J., Grimson R., Mishriki Y. Elevated ras oncogene expression correlates with lymph node metastasis in breast cancer patients. J Clin Onc 1986; 4: 1321–1325
   PubMed Web of Science ®Google Scholar
• Viola M. V., Fromowitz F., Oravez S. Expression of ras oncogene p21 in prostate cancer. NEJM 1986; 314: 133–137
   PubMed Web of Science ®Google Scholar
• Robinson A., Williams A. R. W., Piris J. Evaluation of a monoclonal antibody to ras peptide, RAP-5, claimed to bind preferentially to cells of infiltrating carcinomas. Br. J. Cancer 1988; 54: 877–881
   Web of Science ®Google Scholar
• Samowitz W. S., Paul G., Hamilton S. R. Reported binding of monoclonal antibody RAP-5 to formalin-fixed tissue sections is not indicative of ras p21 expression. Hum Pathol 1988; 19: 127
   PubMed Web of Science ®Google Scholar
• Gutheil J. C., Mane S. M., Kapil V., Needleman S. W. Immunoprecipitation of cell lysates with RAP-5 does not specifically detect ras oncogene product, p21. Human Pathology 1989; 20: 1176–1180
   PubMed Web of Science ®Google Scholar
• Gutheil J. C., Mane S. M., Bass K. N., Lee E. J., Needleman S. W. Ras gene product level determination in leukemic blast cells. Biotech, submitted
   Google Scholar
• Schwartz R. C., Stanton L. W., Riley S. C., Marcu K. B., Witte O. N. Synergism of v-myc and v-Ha-ras in the in vitro neoplastic progression of murine lymphoid cells. Mol Cell Biol 1986; 16: 3221–3231
   Google Scholar
• Mavilio F., Sposi N. M., Petrini M., Bottero L., Marinucci M., DeRossi G., Amadori S., Mandelli F., Deschle C. Expression of cellular oncogenes in primary cells from human acute leukemia. Proc Nat'l Acad Sci, USA 1986; 83: 4394–4398
   PubMed Web of Science ®Google Scholar
• Slamon D. J., DeKernion J. B., Verma I. M., Cline M. J. Expression of cellular oncogenes in human malignancies. Science 1984; 224: 256–262
   PubMed Web of Science ®Google Scholar
• Weinberg R. A. Oncogenes, antioncogenes and the molecular bases of multistep carcinogenesis. Can Res 1989; 49: 3713–3721, 1989.
   PubMed Web of Science ®Google Scholar
• Huber B. E., Dearfield K. L., Williams J. R., Heilman C. A., Thorgeirsson S. S. Tumorigenicity and transcriptional modulation of c-myc and n-ras oncogenes in a human hepatoma cell line. Can Res 1985; 45: 4322–4329
   PubMed Web of Science ®Google Scholar
• Ernst T. J., Gazdar A., Ritz J., Shipp M. A. Identification of a second transforming gene, rasH in a human multiple myeloma line with a rearranged c-myc allele. Blood 1983; 72: 1163–1167
   Google Scholar
• Carloni G., Champ B., Vilarem M. J., Lavialle C., Cassingena R. Activation of c-Ki-ras coexists with c-myc amplification in cells from a nude mouse tumor induced by the human breast carcinoma cell line SW613-S. FEB 1988; 233: 268–272
   PubMed Web of Science ®Google Scholar